SCHEMBL4697112

SCHEMBL4697112

CCn1c(C(=C=O)CN(C)C)cnc1C(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4699937 0.88
SCHEMBL1448754 0.77
SCHEMBL4700152 0.76 PDE1A (0.33)
SCHEMBL1447305 0.73 HTT (0.38) HTT
SCHEMBL1449077 0.70 HTT (0.37) HTT
SCHEMBL1555035 0.61 P2RX7 (0.35)
SCHEMBL25028002 0.61 SMN1; SMN2 (0.37)
SCHEMBL4713935 0.60 KDM4E (0.43)
SCHEMBL1652097 0.59 HDAC1 (0.44)
SCHEMBL19368026 0.59 SMN1; SMN2 (0.35) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912974-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS AstraZeneca AB (SE) 2008-04-23 EP disclosed
WO-2007015064-A1 IMIDAZOLYL-PYRIMIDINE COMPOUNDS FOR USE IN THE TREATMENT OF PROLIFERATIVE DISORDERS ASTRAZENECA AB (SE) 2007-02-08 WO disclosed